ZBH- Zimmer Biomet Holdings, Inc.
Healthcare · Medical Devices
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 21 analysts
12-Month Price Target
$107.57
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $93.49
Graham Number
√(22.5 × EPS × Book Value)
$78.36
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$15.91
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
8/10
80% score
Pays dividends
14Y hist.14+ years of dividend history
Dividend consistency (5Y+)
14 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
6.4%Return on equity - measures how efficiently capital is used
Positive profit margin
9.5%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+4.8%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
+33.8%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
60.17×Low financial leverage reduces risk of distress
Current ratio above 1
1.69×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$206M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
1.03%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Nov 5, 2026
54
days
EPS (TTM)
$4.12
P/E (TTM)
22.7
Fwd P/E
10.3
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
1.03%
5Y Avg Annual
$0.8640
Last Payment
$0.2400
Ex-Date
06/25/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest06/25/2026 | 07/25/2026 | $0.2400 | 1.03% |
03/31/2026 | 04/30/2026 | $0.2400 | 1.03% |
12/30/2025 | 01/29/2026 | $0.2400 | 1.03% |
09/30/2025 | 10/30/2025 | $0.2400 | 1.03% |
06/26/2025 | 07/26/2025 | $0.2400 | 1.03% |
03/31/2025 | 04/30/2025 | $0.2400 | 1.03% |
12/30/2024 | 01/29/2025 | $0.2400 | 1.03% |
09/30/2024 | 10/30/2024 | $0.2400 | 1.03% |
Magic Number
Shares needed to self-fund your next purchase
$93.49
Price
$0.2400
Last div. (quarterly)
390
shares
Own 390 ZBH shares ($36,461.10) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$36,461.10
New shares / year
+4 shares
Dividend Calculator
1.03% yieldEstimate ZBH dividend income at the current rate.
Per year
$102.68
Per month
$8.56
≈ 107 shares at $0.96/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
ZBH vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Sector
Healthcare
Industry
Medical Devices
Location
Warsaw, United States
Employees
17,000
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Zimmer Biomet Holdings, Inc. (ZBH) stock trades at $93.49, up 1.14% on the day. With a market capitalization of $17.83 billion, ZBH is a large-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 22.7, a forward P/E of 10.3 and earnings per share (EPS) of $4.12. Over the most recent period the company reported 5% year-over-year revenue growth and a net profit margin of 9.5%. Below you'll find ZBH's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
ZBH - Frequently Asked Questions
Is Zimmer Biomet Holdings, Inc. (ZBH) a good stock to buy in 2026?
Zimmer Biomet Holdings, Inc. (ZBH) shows risks such as high leverage (debt/equity of 60.2). Whether ZBH is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is ZBH's stock price today?
Zimmer Biomet Holdings, Inc. (ZBH) trades at $93.49, up 1.14% on the session. Prices on this page update throughout the trading day.
Does ZBH pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. pays an annual dividend of $0.96 per share, a dividend yield of 1.03%. The most recent ex-dividend date was September 30, 2026. Its payout ratio is about 23% of earnings.
Is ZBH overvalued?
With a P/E ratio of 22.7×, ZBH trades at a roughly market-average valuation for the healthcare sector. Its PEG ratio is 0.58 (below 1, which can signal growth at a reasonable price). See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is ZBH's market cap?
Zimmer Biomet Holdings, Inc. (ZBH) has a market capitalization of $17.83 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.